NCT03875469View on ClinicalTrials.gov

Study to Test the Usability of a New Injector to Administer Contrast Media Into Humans for Diagnostic Purposes

NACompletedINTERVENTIONAL
Enrollment

425

Participants

Timeline

Start Date

June 21, 2019

Primary Completion Date

March 10, 2020

Study Completion Date

March 10, 2020

Conditions
Computed Tomography
Interventions
DEVICE

Centargo injector (BPI 1000045)

Contrast-enhanced computer tomography conducted with Centargo injector

DEVICE

Stellant MP injector

Contrast-enhanced computer tomography conducted with Stellant MP injector

Trial Locations (2)

2160

Medscan, Merrylands

6229

Maastricht University Medical Center, Maastricht

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT03875469 - Study to Test the Usability of a New Injector to Administer Contrast Media Into Humans for Diagnostic Purposes | Biotech Hunter | Biotech Hunter